| 000 | 01721 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515193928.0 | ||
| 264 | 0 | _c20100218 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1087-2108 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrover, Raminder K | |
| 245 | 0 | 0 |
_aA case of bullous disease limited to the skin illustrates the spectrum of neoplasia-induced autoimmunity. _h[electronic resource] |
| 260 |
_bDermatology online journal _cJul 2009 |
||
| 300 |
_a5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdiagnosis |
| 650 | 0 | 4 | _aComplement Fixation Tests |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xcomplications |
| 650 | 0 | 4 |
_aParaneoplastic Syndromes _xdiagnosis |
| 650 | 0 | 4 |
_aPemphigus _xdiagnosis |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSepsis _xcomplications |
| 650 | 0 | 4 |
_aSkin Diseases, Vesiculobullous _xdiagnosis |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aStites, P Craig | |
| 700 | 1 | _aHelm, Thomas N | |
| 700 | 1 | _aHashimoto, Takashi | |
| 700 | 1 | _aBeutner, Ernst H | |
| 773 | 0 |
_tDermatology online journal _gvol. 15 _gno. 7 _gp. 5 |
|
| 999 |
_c19290542 _d19290542 |
||